Tonix Pharmaceuticals Holding (TNXP) Total Debt (2010 - 2024)
Tonix Pharmaceuticals Holding (TNXP) posted Total Debt of $11.5 million for Q4 2024, up 43.52% on a QoQ basis from $8.0 million in Q3 2024, and down 14.08% year-over-year from $13.4 million in Q1 2024.
Powered by 
Analysis
Tonix Pharmaceuticals Holding (TNXP) Total Debt (2010 - 2024) Analysis & Trends
Tonix Pharmaceuticals Holding has reported Total Debt for 6 years, with the latest figure at $11.5 million in Q4 2024.
- On a quarterly basis, Total Debt fell 14.08% year-over-year to $11.5 million in Q4 2024; TTM through Dec 2024 was $11.5 million, a 14.08% decrease from a year earlier, with the FY2024 full-year figure at $11.5 million, down 14.08% from the prior year.
- Total Debt was $11.5 million for Q4 2024 at Tonix Pharmaceuticals Holding, up from $8.0 million in the prior quarter.
- The five-year high for Total Debt was $13.4 million in Q4 2023, with the low at $8.0 million in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 60.73 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 70.82 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 53.91 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 9.59 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 63.19 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 25.19 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | 1.07 Bn |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 38.81 Mn |
| 10 | Tonix Pharmaceuticals Holding | 220.65 Mn | 220.65 Mn | 12.84 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 11.47 Mn |
| Sep 30, 2024 | 7.99 Mn |
| Jun 30, 2024 | 8.49 Mn |
| Mar 31, 2024 | 8.98 Mn |
| Dec 31, 2023 | 13.35 Mn |
| Jun 30, 2014 | 280,000.00 |
| Mar 31, 2014 | 280,000.00 |
| Dec 31, 2013 | 280,000.00 |
| Sep 30, 2013 | 280,000.00 |
| Dec 31, 2011 | 150,000.00 |
| Sep 30, 2011 | 10,000.00 |
| Jun 30, 2011 | 10,000.00 |
| Dec 31, 2010 | 10,000.00 |